CYTENA and ExcellGene to develop automated work-flows for biotherapeutics cell line development
CYTENA, a BICO group company and a leading provider of high-precision instruments for handling biological cells, will collaborate with ExcellGene, a leading biologics Contract Development & Manufacturing Organizations (CDMO) that manufactures recombinant proteins, to streamline cell line development workflows for highly-efficient monoclonal antibody (mAb) and complex therapeutic protein manufacturing, which enables important improvements to the […]
